Impact of antiretroviral therapy on intestinal lymphoid tissues in HIV infection.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 17147469.
- Also identified by PMC identifier 1762071.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Veazey and Lackner discuss a new study which found that most patients who start antiretroviral drugs as early as possible after HIV infection still do not experience complete restoration of intestinal CD4+ T cells to baseline levels.
Medical subject headings
- Anti-Retroviral Agents
- HIV Infections
- Intestinal Mucosa
- Lymphoid Tissue